Press kit
Betawise: your glucose data, explained
Betawise is a free web app that turns a CGM export into a plain-language summary of the last two weeks, so people with diabetes can understand their patterns between appointments and bring better questions to their care team. It launches on World Diabetes Day, November 14, 2026.
Quick facts
- Price: free. No ads, no account.
- Works with: Dexcom Clarity and LibreView CSV exports, and Nightscout.
- Privacy: imported files are analyzed in the browser and stored only on the person’s device. Optional AI explanations receive summary statistics, never raw readings.
- Signature feature: “Your two weeks, explained,” a short tap-through story of time in range, the steadiest and hardest parts of the day, one pattern to review, and questions for the next visit.
- Methods: metrics follow the International Consensus on Time in Range (2019), the glucose management indicator (2018) and the Glycemia Risk Index (2023). See methods and limitations.
- Try it: betawise.org/app.html?demo=sarah opens a sample with simulated data, no sign-up.
The founder
Betawise was built by Daniel, who lives with diabetes. [Two or three sentences in Daniel’s words: diagnosis, what the months between appointments feel like, and why Daniel built Betawise.]
[Founder photo, at least 1200 px, and a one-line title.]
Why now
Many people with diabetes see a specialist only a few times a year, while a CGM records a reading every five to fifteen minutes. Most CGM apps show charts. Betawise explains in plain words what those charts say, so the time between visits is easier to make sense of.
Images
All images use simulated sample data. You may use them in coverage of Betawise.
Brand
The name and the β logo nod to beta cells, the cells that make insulin. Colors: deep teal #0F2E33, teal #0B6B72, light teal accent #6FD3D9, warm off-white #F8F6F2. Headlines are set in Fraunces. Please write the name as “Betawise”.
What Betawise is not
Betawise provides summaries of historical CGM data and educational explanations. It does not provide real-time alerts or insulin or medication dosing advice, and it is not a medical device. Please don’t describe it as treating or managing diabetes.
Contact
For interviews, demos or images: [press contact email].


